Jump to Content Jump to Main Navigation
User Account
  • Sign In to save searches and organize your favorite content.
  • Not registered? Sign up
  • My Content (0)

    Recently viewed (0)

    • Save Entry
  • Searches (0)

    Recently viewed (0)

    • Save Search
More
  • Subscriptions
  • Join E-mail List
  • Help
JNCCN
Menu
  • Home
  • Content
    • Current Issue
    • Past Issues
    • Featured Online Content
    • Supplements
    • NCCN Meeting Highlights
    • JNCCN In the News
    • World Cancer Day
  • COVID-19
  • CE
  • JNCCN 360
  • Author Center
    • Call for Papers
    • Submit a Manuscript
    • Information for Authors
    • Reprints/Permissions
  • About
    • JNCCN
    • Editorial Board
    • Editorial Calendar
    • NCCN
    • Harborside
Search
Close
Advanced Search Help

Featured Online Content

in Journal of the National Comprehensive Cancer Network
Online ISSN:
1540-1413
Print ISSN:
1540-1405
Cover Journal of the National Comprehensive Cancer Network
  • Get eTOC Alerts
  • Get Ahead of Print Alerts
  • Get Citation Alerts
  • Randomized Trial of a Supportive Psychotherapy for Parents of Adolescents and Young Adults With Hematologic Malignancies
    By: Michael Koehler, Susanne Hoppe, Siegfried Kropf, Anke Lux, Rainer Bartsch, Bernhard Holzner, Juergen Krauter, Axel Florschütz, Kathleen Jentsch-Ullrich, Joerg Frommer, Hans-Henning Flechtner, and Thomas Fischer
    Pages: 1–15
  • Response of Leptomeningeal Metastasis of Breast Cancer With a HER2/neu Activating Variant to Tucatinib: A Case Report
    By: Fengting Yan, Kristine J. Rinn, Jonathon A. Kullnat, Aimee Y. Wu, Maura D. Ennett, Elizabeth L. Scott, and Henry G. Kaplan
    Pages: 1–8
  • Adjuvant Hormone Therapy–Related Hot Flashes Predict Treatment Discontinuation and Worse Breast Cancer Prognosis
    By: Erwei Zeng, Wei He, Karin E. Smedby, and Kamila Czene
    Pages: 1–7
  • Economic Analysis of Exclusionary EGFR Test Versus Up-Front NGS for Lung Adenocarcinoma in High EGFR Mutation Prevalence Areas
    By: Szu-Chun Yang, Yi-Chen Yeh, Yi-Lin Chen, and Chao-Hua Chiu
    Pages: 1–9
  • Personalizing First-Line Management of Metastatic Renal Cell Carcinoma: Leveraging Current and Novel Therapeutic Options
    By: Kelly N. Fitzgerald and Chung-Han Lee
    Pages: 1–9
  • Near Complete Response to Trametinib Treatment in Histiocytic Sarcoma Harboring a Somatic KRAS Mutation
    By: Boyu Hu, Jay L. Patel, Randa Tao, Richard B. Cannon, Marcus Monroe, and Gaurav Goyal
    Pages: 1–4
  • Current Surveillance After Treatment is Not Sufficient for Patients With Rectal Cancer With Negative Baseline CEA
    By: Dingcheng Shen, Xiaolin Wang, Heng Wang, Gaopo Xu, Yumo Xie, Zhuokai Zhuang, Ziying Huang, Juan Li, Jinxin Lin, Puning Wang, Meijin Huang, Yanxin Luo, and Huichuan Yu
    Pages: 1–10
  • Uptake of Recommendations for Posttreatment Cancer-Related Fatigue Among Breast Cancer Survivors
    By: Antonio Di Meglio, Cecile Charles, Elise Martin, Julie Havas, Arnauld Gbenou, Jean-Daniel Flaysakier, Anne-Laure Martin, Sibille Everhard, Enora Laas, Nicolas Chopin, Laurence Vanlemmens, Christelle Jouannaud, Christelle Levy, Olivier Rigal, Marion Fournier, Patrick Soulie, Florian Scotte, Barbara Pistilli, Agnes Dumas, Gwenn Menvielle, Fabrice André, Stefan Michiels, Sarah Dauchy, and Ines Vaz-Luis
    Pages: 1–13
  • Adoption of Patient-Generated Health Data in Oncology: A Report From the NCCN EHR Oncology Advisory Group
    By: Peter D. Stetson, Nadine J. McCleary, Travis Osterman, Kavitha Ramchandran, Amye Tevaarwerk, Tracy Wong, Jessica M. Sugalski, Wallace Akerley, Annette Mercurio, Finly J. Zachariah, Jonathan Yamzon, Robert C. Stillman, Peter E. Gabriel, Tricia Heinrichs, Kathleen Kerrigan, Shiven B. Patel, Scott M. Gilbert, and Everett Weiss
    Pages: 1–6
  • COVID-19 and Cancer Center Operations: Lessons Learned From the NCCN Best Practices Committee
    By: Jessica M. Sugalski, Theresa Franco, Lawrence N. Shulman, Elizabeth Souza, Ephraim Hochberg, Anne Chiang, Scott Lawrence, Diana Krause, and Timothy Kubal
    Pages: 1–4
  • Breast Cancer Diagnostics, Therapy, and Outcomes in Sub-Saharan Africa: A Population-Based Registry Study
    By: Walburga Yvonne Joko-Fru, Mirko Griesel, Nikolaus Christian Simon Mezger, Lucia Hämmerl, Tobias Paul Seraphin, Jana Feuchtner, Henry Wabinga, Guy N’da, Assefa Mathewos, Bakarou Kamaté, Judith Nsonde Malanda, Freddy Houéhanou Rodrigue Gnangnon, Gladys Chebet Chesumbai, Anne Korir, Cesaltina Lorenzoni, Annelle Zietsman, Margaret Ziona Borok, Biying Liu, Christoph Thomssen, Paul McGale, Ahmedin Jemal, Donald Maxwell Parkin, and Eva Johanna Kantelhardt
    Pages: 1–11
  • Increasing Financial Payments From Industry to Medical Oncologists in the United States, 2014–2017
    By: Mohammed W. Rahman, Niti U. Trivedi, Peter B. Bach, and Aaron P. Mitchell
    Pages: 1–9
  • Physician Interactions With Industry: Striking the Right Balance
    By: Cory L. Anand and Raed A. Dweik
    Pages: 1–3
  • Navigating Nodal Metrics for Node-Positive Gastric Cancer in the United States: An NCDB-Based Study and Validation of AJCC Guidelines
    By: Derek J. Erstad, Mariela Blum, Jeannelyn S. Estrella, Prajnan Das, Bruce D. Minsky, Jaffer A. Ajani, Paul F. Mansfield, Naruhiko Ikoma, and Brian D. Badgwell
    Pages: 1–12
  • Factors Affecting Genetic Consultation in Adolescent and Young Adult Patients With Sarcoma
    By: Grace E. McKay, Anna L. Zakas, Fauzia Osman, and Amanda Parkes
    Pages: 1–8
  • Association of Social Support With Overall Survival and Healthcare Utilization in Patients With Aggressive Hematologic Malignancies
    By: P. Connor Johnson, Netana H. Markovitz, Tamryn F. Gray, Sunil Bhatt, Ryan D. Nipp, Nneka Ufere, Julia Rice, Matthew J. Reynolds, Mitchell W. Lavoie, Carlisle E.W. Topping, Madison A. Clay, Charlotta Lindvall, and Areej El-Jawahri
    Pages: 1–7
  • Improving Interdisciplinary Communication: Barriers and Facilitators for Implementation of Standardized Structured Reporting in Oncology
    By: Julie E.M. Swillens, Quirinus J.M. Voorham, Iris D. Nagtegaal, and Rosella P.M.G. Hermens
    Pages: 1–11
  • Associations With Definitive Outcomes and Clinical Benefit of Cancer Drugs at the Time of Marketing Approval and in the Postmarketing Period
    By: Aida Bujosa, Consolación Moltó, Thomas J. Hwang, José Carlos Tapia, Kerstin N. Vokinger, Arnoud J. Templeton, Ignasi Gich, Agustí Barnadas, Eitan Amir, and Ariadna Tibau
    Pages: 1–9
  • Impact of Nonadherence to NCCN Adjuvant Radiotherapy Initiation Guidelines in Head and Neck Squamous Cell Carcinoma in an Underserved Urban Population
    By: Anusha Ponduri, David Z. Liao, Nicolas F. Schlecht, Gregory Rosenblatt, Michael B. Prystowsky, Rafi Kabarriti, Madhur Garg, Thomas J. Ow, Bradley A. Schiff, Richard V. Smith, and Vikas Mehta
    Pages: 1–7
  • BBCIC Research Network Analysis of First-Cycle Prophylactic G-CSF Use in Patients Treated With High–Neutropenia Risk Chemotherapy
    By: Pamala A. Pawloski, Cara L. McDermott, James H. Marshall, Vanita Pindolia, Catherine M. Lockhart, Catherine A. Panozzo, Jeffrey S. Brown, and Bernadette Eichelberger
  • Harmonized Outcome Measures for Use in Non–Small Cell Lung Cancer Patient Registries and Clinical Practice
    By: Martin J. Edelman, Daniel P. Raymond, Dwight H. Owen, Michelle B. Leavy, Kari Chansky, Sriram Yennu, Felix G. Fernandez, Carolyn J. Presley, Tithi Biswas, Gwendolyn P. Quinn, Matthew B. Schabath, Seth Sheffler-Collins, Laura Chu, and Richard E. Gliklich
  • Impact of Psychological Distress on Treatment Timeliness in Oncology Patients at a Safety-Net Hospital
    By: Sheshadri Madhusudhana, Michelle Gates, Daulath Singh, Punita Grover, Mahathi Indaram, and An-Lin Cheng
  • Delays in Care Associated With Non–English-Speaking Patients With Breast Cancer
    By: Katy E. Balazy, Cecil M. Benitez, Paulina M. Gutkin, Clare E. Jacobson, Rie von Eyben, and Kathleen C. Horst
  • Melanoma Metastases to the Adrenal Gland Are Highly Resistant to Immune Checkpoint Inhibitors
    By: Jessica S.W. Borgers, Richard P. Tobin, Robert J. Torphy, Victoria M. Vorwald, Robert J. Van Gulick, Carol M. Amato, Dasha T. Cogswell, Tugs-Saikhan Chimed, Kasey L. Couts, Adrie Van Bokhoven, Christopher D. Raeburn, Karl D. Lewis, Joshua Wisell, Martin D. McCarter, Rao R. Mushtaq, and William A. Robinson
  • Financial Implications of Early Hospital Discharge After AML-Like Induction Chemotherapy: A 4-Year Retrospective Analysis
    By: Nathan J. Moore, Megan Othus, Anna B. Halpern, Nicholas P. Howard, Linyi Tang, Kyle E. Bastys, Mary-Elizabeth M. Percival, Paul C. Hendrie, Garrett A. Hartley, Verna L. Welch, Elihu H. Estey, and Roland B. Walter
    Pages: 1–10
  • Prospective Study of Fertility Preservation in Young Women With Breast Cancer in Mexico
    By: Cynthia Villarreal-Garza, Fernanda Mesa-Chavez, Alejandra Plata de la Mora, Melina Miaja-Avila, Marisol Garcia-Garcia, Alan Fonseca, Sylvia de la Rosa-Pacheco, Marlid Cruz-Ramos, Manuel Rolando García Garza, Alejandro Mohar, and Enrique Bargallo-Rocha
    Pages: 1–8
  • Racial Background and Health Behaviors Among Adults With Cancer in Canada: Results of a National Survey
    By: Omar Abdel-Rahman
    Pages: 1–9
  • Disparate Use of Chemoradiation in Elderly Patients With Localized Anal Cancer
    By: Eric D. Miller, Ansel P. Nalin, Dayssy A. Diaz Pardo, Andrea L. Arnett, Emily Huang, Alessandra C. Gasior, Pannaga Malalur, Hui-Zi Chen, Terence M. Williams, and Jose G. Bazan
    Pages: 1–9
  • National Quality Measure Compliance for Palliative Bone Radiation Among Patients With Metastatic Non–Small Cell Lung Cancer
    By: Stephen R. Grant, Benjamin D. Smith, Lauren E. Colbert, Qunyh-Nhu Nguyen, James B. Yu, Steven H. Lin, and Aileen B. Chen
    Pages: 1–6
  • Clinical Outcomes With Abemaciclib After Prior CDK4/6 Inhibitor Progression in Breast Cancer: A Multicenter Experience
    By: Seth A. Wander, Hyo S. Han, Mark L. Zangardi, Andrzej Niemierko, Veronica Mariotti, Leslie S.L. Kim, Jing Xi, Apurva Pandey, Siobhan Dunne, Azadeh Nasrazadani, Avinash Kambadakone, Casey Stein, Maxwell R. Lloyd, Megan Yuen, Laura M. Spring, Dejan Juric, Irene Kuter, Ioannis Sanidas, Beverly Moy, Therese Mulvey, Neelima Vidula, Nicholas J. Dyson, Leif W. Ellisen, Steven Isakoff, Nikhil Wagle, Adam Brufsky, Kevin Kalinsky, Cynthia X. Ma, Joyce O’Shaughnessy, and Aditya Bardia
    Pages: 1–8
  • Outcomes of COVID-19 in Patients With a History of Cancer and Comorbid Cardiovascular Disease
    By: Sarju Ganatra, Sourbha S. Dani, Robert Redd, Kimberly Rieger-Christ, Rushin Patel, Rohan Parikh, Aarti Asnani, Vigyan Bang, Katherine Shreyder, Simarjeet S. Brar, Amitoj Singh, Dhruv S. Kazi, Avirup Guha, Salim S. Hayek, Ana Barac, Krishna S. Gunturu, Corrine Zarwan, Anne C. Mosenthal, Shakeeb A. Yunus, Amudha Kumar, Jaymin M. Patel, Richard D. Patten, David M. Venesy, Sachin P. Shah, Frederic S. Resnic, Anju Nohria, and Suzanne J. Baron
    Pages: 1–10
  • Creative Strategies Implemented During the Coronavirus Pandemic That Will Impact the Future of Cancer Care
    By: Jessica Sugalski, Theresa Franco, Lawrence N. Shulman, Pelin Cinar, James Bachman, Jennie R. Crews, MiKaela Olsen, Alyssa Schatz, and Timothy Kubal
    Pages: 1–5
  • Telemedicine in Oncology and Reimbursement Policy During COVID-19 and Beyond
    By: Sheetal M. Kircher, Mary Mulcahy, Aparna Kalyan, Christine B. Weldon, Julia R. Trosman, and Al B. Benson III
    Pages: 1–7
  • Considerations for Use of Hematopoietic Growth Factors in Patients With Cancer Related to the COVID-19 Pandemic
    By: Elizabeth A. Griffiths, Laura M. Alwan, Kimo Bachiashvili, Anna Brown, Rita Cool, Peter Curtin, Mark B. Geyer, Ivana Gojo, Avyakta Kallam, Wajih Z. Kidwai, Dwight D. Kloth, Eric H. Kraut, Gary H. Lyman, Sudipto Mukherjee, Lia E. Perez, Rachel P. Rosovsky, Vivek Roy, Hope S. Rugo, Sumithira Vasu, Martha Wadleigh, Peter Westervelt, and Pamela S. Becker
    Pages: 1–4
  • Save
  • Email this content

    Share Link


    Copy this link, or click below to email it to a friend
    Email this content
    or copy the link directly:
    The link was not copied. Your current browser may not support copying via this button.
    Link copied successfully

  • Collapse
  • Expand
  • Advertising
  • Terms of Use
  • Privacy Policy
  • Contact Us
  • Permissions
  • Disclaimer

© 2019-2022 National Comprehensive Cancer Network

Follow us on: Share Share Share

Powered by:

PubFactory
  • [3.238.176.43]
  • 3.238.176.43
Close
Edit

Character limit 500/500

@!

Character limit 500/500